{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:14:10Z","timestamp":1783433650161,"version":"3.54.6"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wellcome Trust Institutional Strategic Support Fund","award":["204826\/Z\/16\/Z"],"award-info":[{"award-number":["204826\/Z\/16\/Z"]}]},{"DOI":"10.13039\/100013961","name":"Robertson Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013961","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UKRI EPSRC","award":["EP\/X021793\/1"],"award-info":[{"award-number":["EP\/X021793\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Schistosomiasis control relies on the continued effectiveness of praziquantel (PZQ), yet individual and spatial heterogeneity in PZQ efficacy in the context of repeated mass drug administration (MDA) remains poorly understood. This study aimed to identify individual and spatial determinants of PZQ efficacy against\n                      <jats:italic>Schistosoma mansoni<\/jats:italic>\n                      in rural Uganda.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We studied 3870 participants aged 5\u201390 years from 52 villages in Pakwach, Buliisa, and Mayuge districts in Uganda. Participants were recruited to the SchistoTrack cohort in January\u2013February of 2022 and 2023. Participants received PZQ and were followed up four to five weeks later to assess cure using Kato\u2013Katz (KK) microscopy and point-of-care circulating cathodic antigen (POC-CCA) tests. Logistic regression models were used to identify predictors of cure, defined as a 100% egg reduction rate (ERR). We explored a comprehensive set of 18 sociodemographic, biomedical, water, sanitation, and hygiene, and spatial factors. Subgroup analyses were conducted for adults (aged 18\u201390) versus children (aged 5\u201317). Spatial autocorrelation in the outcome and model residuals was assessed using join count statistics and Moran\u2019s\n                      <jats:italic>I<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 3870 clinical participants, 3704 (95.7%) received PZQ, and 3395 of these had complete clinical data. Among the 3395 treated participants, 1406 (41.4%) were infected with\n                      <jats:italic>S. mansoni<\/jats:italic>\n                      at baseline. The overall cure rate (ERR of 100%) was 76.3%, ranging from 68.9% to 85.4% across districts. Higher odds of cure were associated with older age (OR 1.34) and lower baseline infection intensity (moderate\/heavy vs light OR 0.39\u22120.61). Greater height was associated with lower odds of cure (OR 0.99), which was driven by adults. Compared with Mayuge district, participants in Western districts had lower odds of cure (OR 0.48\u22120.53). In children, greater distance to water sites with snail presence was linked to higher odds of cure (OR 1.05 per 100m). Results were similar when using POC-CCA outcomes. Spatial clustering of treatment outcomes was observed by district, but no residual spatial autocorrelation remained after accounting for district effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Incorporating spatial analyses, refining dose assessment, and strengthening post-MDA monitoring may help maintain PZQ effectiveness and support sustainable schistosomiasis control efforts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-026-07497-9","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:55:02Z","timestamp":1781589302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Individual and spatial heterogeneity of praziquantel efficacy against Schistosoma mansoni within the context of repeated mass drug administration"],"prefix":"10.1186","volume":"19","author":[{"given":"Melissa A.","family":"Iacovidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Reitzug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Enzaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Asiimwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Nambatya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Nakato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Semakula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Nabatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcis B.","family":"Kabatereine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goylette F.","family":"Chami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"7497_CR1","unstructured":"WHO. WHO guideline on control and elimination of human schistosomiasis. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"7497_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003286","volume":"8","author":"J Zwang","year":"2014","unstructured":"Zwang J, Olliaro PL. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials. PLoS Negl Trop Dis. 2014;8:e3286.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13071-016-1958-7","volume":"10","author":"J Zwang","year":"2017","unstructured":"Zwang J, Olliaro P. Efficacy and safety of praziquantel 40\u00a0mg\/kg in preschool-aged and school-aged children: a meta-analysis. Parasit Vectors. 2017;10:47.","journal-title":"Parasit Vectors"},{"key":"7497_CR4","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1038\/s41598-024-84621-8","volume":"15","author":"M Sisay","year":"2025","unstructured":"Sisay M, Hailu T, Damtie D, Geta K, Zelalem L, Misganaw D. Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis. Sci Rep. 2025;15:4642.","journal-title":"Sci Rep"},{"key":"7497_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/2625255","volume":"2021","author":"T Hailegebriel","year":"2021","unstructured":"Hailegebriel T, Nibret E, Munshea A. Efficacy of Praziquantel for the Treatment of Human Schistosomiasis in Ethiopia: a systematic review and meta-analysis. J Trop Med. 2021;2021:1\u201312.","journal-title":"J Trop Med"},{"key":"7497_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009189","volume":"15","author":"M Fukushige","year":"1977","unstructured":"Fukushige M, Chase-Topping M, Woolhouse ME, Mutapi F. Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy. PLoS Negl Trop Dis. 1977;15:e0009189.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/2024.08.29.610291","author":"DJ Berger","year":"2024","unstructured":"Berger DJ, Park SK, Crellen T, Vianney TJ, Kabatereine NB, Cotton JA, et al. Extensive transmission and variation in a functional receptor for praziquantel resistance in endemic Schistosoma mansoni. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.08.29.610291.","journal-title":"bioRxiv"},{"key":"7497_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010188","volume":"16","author":"TJ Vianney","year":"2022","unstructured":"Vianney TJ, Berger DJ, Doyle SR, Sankaranarayanan G, Serubanja J, Nakawungu PK, et al. Genome-wide analysis of Schistosoma mansoni reveals limited population structure and possible praziquantel drug selection pressure within Ugandan hot-spot communities. PLoS Negl Trop Dis. 2022;16:e0010188.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008277","volume":"14","author":"PL Olliaro","year":"2020","unstructured":"Olliaro PL, Coulibaly JT, Garba A, Halleux C, Keiser J, King CH, et al. Efficacy and safety of single-dose 40 mg\/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: an individual participant data meta-analysis. PLoS Negl Trop Dis. 2020;14:e0008277.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13071-016-1312-0","volume":"9","author":"M Walker","year":"2016","unstructured":"Walker M, Mabud TS, Olliaro PL, Coulibaly JT, King CH, Raso G, et al. New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel. Parasit Vectors. 2016;9:41.","journal-title":"Parasit Vectors"},{"key":"7497_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.07.007","author":"S Anjorin","year":"2024","unstructured":"Anjorin S, Nabatte B, Mpooya S, Tinkitina B, Opio CK, Kabatereine NB. Epidemiology of periportal fibrosis and relevance of current Schistosoma mansoni infection within the context of repeated mass drug administration in rural Uganda: a population-based, cross-sectional study. Lancet Microbe. 2024. https:\/\/doi.org\/10.1016\/j.lanmic.2024.07.007.","journal-title":"Lancet Microbe"},{"key":"7497_CR12","doi-asserted-by":"publisher","first-page":"9530","DOI":"10.1038\/s41467-024-53519-4","volume":"15","author":"F Reitzug","year":"2024","unstructured":"Reitzug F, Kabatereine NB, Byaruhanga AM, Besigye F, Nabatte B, Chami GF. Current water contact and Schistosoma mansoni infection have distinct determinants: a data-driven population-based study in rural Uganda. Nat Commun. 2024;15:9530.","journal-title":"Nat Commun"},{"key":"7497_CR13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.pt.2020.04.012","volume":"36","author":"CL Faust","year":"2020","unstructured":"Faust CL, Osakunor DN, Downs JA, Kayuni S, Stothard JR, Lamberton PH, et al. Schistosomiasis control: leave no age group behind. Trends Parasitol. 2020;36:582\u201391.","journal-title":"Trends Parasitol"},{"key":"7497_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0035-9203(03)00003-8","volume":"98","author":"G Raso","year":"2004","unstructured":"Raso G, N\u2019Goran EK, Toty A, Luginb\u00fchl A, Adjoua CA, Tian-Bi NT, et al. Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western C\u00f4te d\u2019Ivoire. Trans R Soc Trop Med Hyg. 2004;98:18\u201327.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"7497_CR15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1046\/j.1365-3156.2000.00646.x","volume":"5","author":"J Utzinger","year":"2000","unstructured":"Utzinger J, N\u2019goran EK, Lengeler C, Tanner M. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop Med Int Health. 2000;5:771\u20138.","journal-title":"Trop Med Int Health"},{"key":"7497_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001864","author":"JC Sousa-Figueiredo","year":"2012","unstructured":"Sousa-Figueiredo JC, Betson M, Atuhaire A, Arinaitwe M, Navaratnam AM, Kabatereine NB. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl Trop Dis. 2012. https:\/\/doi.org\/10.1371\/journal.pntd.0001864.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/cid\/ciw506","volume":"63","author":"T Crellen","year":"2016","unstructured":"Crellen T, Walker M, Lamberton PH, Kabatereine NB, Tukahebwa EM, Cotton JA, et al. Reduced efficacy of praziquantel against Schistosoma mansoni is associated with multiple rounds of mass drug administration. Clin Infect Dis. 2016;63:1151\u20139.","journal-title":"Clin Infect Dis"},{"key":"7497_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s41182-020-00204-z","volume":"48","author":"A Tesfie","year":"2020","unstructured":"Tesfie A, Getnet G, Abere A, Yihenew G, Belete Y, Kassa M, et al. Praziquantel is an effective drug for the treatment of Schistosoma mansoni infection among school-aged children in Northwest Ethiopia. Trop Med Health. 2020;48:28.","journal-title":"Trop Med Health"},{"key":"7497_CR19","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/pathogens12091170","volume":"12","author":"J Kabatende","year":"2023","unstructured":"Kabatende J, Ntirenganya L, Mugisha M, Barry A, Ruberanziza E, Bienvenu E, et al. Efficacy of single-dose praziquantel for the treatment of Schistosoma mansoni infections among school children in Rwanda. Pathogens. 2023;12:1170.","journal-title":"Pathogens"},{"key":"7497_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s41182-023-00562-4","volume":"51","author":"T Tadele","year":"2023","unstructured":"Tadele T, Astatkie A, Tadesse BT, Makonnen E, Aklillu E, Abay SM. Efficacy and safety of praziquantel treatment against Schistosoma mansoni infection among pre-school age children in southern Ethiopia. Trop Med Health. 2023;51:72.","journal-title":"Trop Med Health"},{"key":"7497_CR21","first-page":"93","volume":"69","author":"ML Barreto","year":"1991","unstructured":"Barreto ML. Geographical and socioeconomic factors relating to the distribution of Schistosoma mansoni infection in an urban area of north-east Brazil. Bull World Health Organ. 1991;69:93.","journal-title":"Bull World Health Organ"},{"key":"7497_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003296","volume":"8","author":"JE Grimes","year":"2014","unstructured":"Grimes JE, Croll D, Harrison WE, Utzinger J, Freeman MC, Templeton MR. The relationship between water, sanitation and schistosomiasis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2014;8:e3296.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijpddr.2020.10.003","volume":"14","author":"B Levecke","year":"2020","unstructured":"Levecke B, Vlaminck J, Andriamaro L, Ame S, Belizario V, Degarege A, et al. Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs. Int J Parasitol Drugs Drug Resist. 2020;14:183\u20137.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7497_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001773","author":"N Schur","year":"2012","unstructured":"Schur N, Vounatsou P, Utzinger J. Determining treatment needs at different spatial scales using geostatistical model-based risk estimates of schistosomiasis. PLoS Negl Trop Dis. 2012. https:\/\/doi.org\/10.1371\/journal.pntd.0001773.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.101065","author":"BJ Singer","year":"2025","unstructured":"Singer BJ, Gomes M, Coulibaly JT, Daigavane M, Tan ST, Bogoch II. Population-level impact of mass drug administration against schistosomiasis with anthelmintic drugs targeting juvenile schistosomes: a modelling study. Lancet Microbe. 2025. https:\/\/doi.org\/10.1016\/j.lanmic.2024.101065.","journal-title":"Lancet Microbe"},{"key":"7497_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s13071-015-1144-3","volume":"8","author":"D Gurarie","year":"2015","unstructured":"Gurarie D, Yoon N, Li E, Ndeffo-Mbah M, Durham D, Phillips AE, et al. Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa. Parasit Vectors. 2015;8:529.","journal-title":"Parasit Vectors"},{"key":"7497_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.epidem.2017.02.003","volume":"18","author":"J Truscott","year":"2017","unstructured":"Truscott J, Gurarie D, Alsallaq R, Toor J, Yoon N, Farrell S, et al. A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis. Epidemics. 2017;18:29\u201337.","journal-title":"Epidemics"},{"key":"7497_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012464","volume":"18","author":"V Malizia","year":"2024","unstructured":"Malizia V, de Vlas SJ, Roes KC, Giardina F. Revisiting the impact of Schistosoma mansoni regulating mechanisms on transmission dynamics using SchiSTOP, a novel modelling framework. PLoS Negl Trop Dis. 2024;18:e0012464.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007617","volume":"13","author":"NG Exum","year":"2019","unstructured":"Exum NG, Kibira SP, Ssenyonga R, Nobili J, Shannon AK, Ssempebwa JC, et al. The prevalence of schistosomiasis in Uganda: a nationally representative population estimate to inform control programs and water and sanitation interventions. PLoS Negl Trop Dis. 2019;13:e0007617.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR30","unstructured":"University of Oxford.: SchistoTrack: a prospective multimorbidity cohort. https:\/\/www.bdi.ox.ac.uk\/research\/schistotrack. Accessed 22 Sept 2025"},{"key":"7497_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2024-002151","author":"C Puthur","year":"2025","unstructured":"Puthur C, Nabatte B, Tinkitina B, Kabatereine NB, Chami GF. Design and maintenance of community-based cohorts in sub-Saharan Africa: a longitudinal evaluation of participant attrition in SchistoTrack. BMJ Public Health. 2025. https:\/\/doi.org\/10.1136\/bmjph-2024-002151.","journal-title":"BMJ Public Health"},{"key":"7497_CR32","unstructured":"WHO. Routine health information system and health facility data for neglected tropical diseases: Schistosomiasis. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"7497_CR33","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1128\/AAC.44.10.2903-2904.2000","volume":"44","author":"N Castro","year":"2000","unstructured":"Castro N, Medina R, Sotelo J, Jung H. Bioavailability of praziquantel increases with concomitant administration of food. Antimicrob Agents Chemother. 2000;44:2903\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"7497_CR34","first-page":"397","volume":"14","author":"N Katz","year":"1972","unstructured":"Katz N, Chaves A, Pellegrino J, et al. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14:397\u2013400.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"7497_CR35","unstructured":"WHO.: Assessing the efficacy of anthelminthic drugs against schistosomiasis and soil-transmitted helminthiases. Geneva: World Health Organization."},{"key":"7497_CR36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/cid\/civ829","volume":"62","author":"GF Chami","year":"2016","unstructured":"Chami GF, Kontoleon AA, Bulte E, Fenwick A, Kabatereine NB, Tukahebwa EM, et al. Profiling nonrecipients of mass drug administration for schistosomiasis and hookworm infections: a comprehensive analysis of praziquantel and albendazole coverage in community-directed treatment in Uganda. Clin Infect Dis. 2016;62:200\u20137.","journal-title":"Clin Infect Dis"},{"key":"7497_CR37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0035-9203(99)90087-1","volume":"93","author":"A Hall","year":"1999","unstructured":"Hall A, Nokes C, Wen ST, Adjei S, Kihamia C, Mwanri L, et al. Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis. Trans R Soc Trop Med Hyg. 1999;93:653\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"7497_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0013587","volume":"19","author":"P Berry","year":"2025","unstructured":"Berry P, Gazzinelli-Guimaraes PH. Evaluating the efficacy of the praziquantel dose pole for schistosomiasis treatment: a multi-country systematic review. PLoS Negl Trop Dis. 2025;19:e0013587.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR39","unstructured":"WHO. Body mass index (BMI). https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/body-mass-index. Accessed 13 Oct 2025."},{"key":"7497_CR40","unstructured":"WHO. Improved sanitation facilities and drinking-water sources. https:\/\/www.who.int\/data\/nutrition\/nlis\/info\/improved-sanitation-facilities-and-drinking-water-sources. Accessed 13 Oct 2025."},{"key":"7497_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011377","volume":"17","author":"F Reitzug","year":"2023","unstructured":"Reitzug F, Ledien J, Chami GF. Associations of water contact frequency, duration, and activities with schistosome infection risk: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2023;17:e0011377.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258915","volume":"16","author":"O Lamberti","year":"2021","unstructured":"Lamberti O, Kabatereine NB, Tukahebwa EM, Chami GF. Schistosoma mansoni infection risk for school-aged children clusters within households and is modified by distance to freshwater bodies. PLoS ONE. 2021;16:e0258915.","journal-title":"PLoS ONE"},{"key":"7497_CR43","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria. https:\/\/www.R-project.org\/."},{"key":"7497_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1081\/QEN-120001878","volume":"14","author":"TA Craney","year":"2002","unstructured":"Craney TA, Surles JG. Model-dependent variance inflation factor cutoff values. Qual Eng. 2002;14:391\u2013403.","journal-title":"Qual Eng"},{"key":"7497_CR45","unstructured":"Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;65\u201370."},{"key":"7497_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.2517-6161.1948.tb00012.x","volume":"10","author":"PA Moran","year":"1948","unstructured":"Moran PA. The interpretation of statistical maps. J R Stat Soc: Ser B (Methodol). 1948;10:243\u201351.","journal-title":"J R Stat Soc: Ser B (Methodol)"},{"key":"7497_CR47","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s11749-018-0599-x","volume":"27","author":"RS Bivand","year":"2018","unstructured":"Bivand RS, Wong DW. Comparing implementations of global and local indicators of spatial association. TEST. 2018;27:716\u201348.","journal-title":"TEST"},{"key":"7497_CR48","unstructured":"Cliff AD, Ord JK. Spatial processes: models & applications."},{"key":"7497_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/14786440009463897","volume":"50","author":"KX Pearson","year":"1900","unstructured":"Pearson KX. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Lond Edinburgh Dublin Philos Mag J Sci. 1900;50:157\u201375.","journal-title":"Lond Edinburgh Dublin Philos Mag J Sci"},{"key":"7497_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1037\/h0026256","volume":"70","author":"J Cohen","year":"1968","unstructured":"Cohen J. Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213.","journal-title":"Psychol Bull"},{"key":"7497_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/2049-9957-3-47","volume":"3","author":"HD Mazigo","year":"2014","unstructured":"Mazigo HD, Dunne DW, Kinung\u2019hi SM, Nuwaha F. Praziquantel efficacy against Schistosoma mansoni among HIV-1 infected and uninfected adults living in fishing villages along Lake Victoria, Northwest Tanzania. Infect Dis Poverty. 2014;3:47.","journal-title":"Infect Dis Poverty"},{"key":"7497_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pwat.0000038","volume":"1","author":"AR Lampard-Scotford","year":"2022","unstructured":"Lampard-Scotford AR, Pfavayi L, Kasambala M, Choto E, Vengesai A, Lim R, et al. Knowledge, attitudes, practices and behaviours (KAPB) around water, sanitation and hygiene (WASH) in villagers exposed to schistosomiasis in Zimbabwe. PLoS Water. 2022;1:e0000038.","journal-title":"PLoS Water"},{"key":"7497_CR53","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1016\/S2214-109X(19)30370-5","volume":"7","author":"JJ Bigna","year":"2019","unstructured":"Bigna JJ, Noubiap JJ. The rising burden of non-communicable diseases in sub-Saharan Africa. Lancet Glob Health. 2019;7:e1295\u20136.","journal-title":"Lancet Glob Health"},{"key":"7497_CR54","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/nyas.12433","volume":"1311","author":"NP Steyn","year":"2014","unstructured":"Steyn NP, Mchiza ZJ. Obesity and the nutrition transition in Sub-Saharan Africa. Ann N Y Acad Sci. 2014;1311:88\u2013101.","journal-title":"Ann N Y Acad Sci"},{"key":"7497_CR55","doi-asserted-by":"publisher","first-page":"13347","DOI":"10.1073\/pnas.1121051109","volume":"109","author":"KM Mitchell","year":"2012","unstructured":"Mitchell KM, Mutapi F, Savill NJ, Woolhouse ME. Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms. Proc Natl Acad Sci. 2012;109:13347\u201352.","journal-title":"Proc Natl Acad Sci"},{"key":"7497_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgae471","volume":"3","author":"GC Milne","year":"2024","unstructured":"Milne GC, Oettle RC, Whittaker C, Kabatereine NB, Bas\u00e1\u00f1ez MG, Webster JP, et\u00a0al. Revisiting immunity vs. exposure in schistosomiasis: a mathematical modeling study of delayed concomitant immunity. PNAS Nexus. 2024;3:pgae471.","journal-title":"PNAS Nexus"},{"key":"7497_CR57","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1128\/IAI.00641-12","volume":"80","author":"CM Fitzsimmons","year":"2012","unstructured":"Fitzsimmons CM, Jones FM, Pinot\u00a0de Moira A, Protasio AV, Khalife J, Dickinson HA, et\u00a0al. Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis? Infect Immunity. 2012;80:4264\u201370.","journal-title":"Infect Immunity"},{"key":"7497_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202499","volume":"13","author":"A Fuss","year":"2018","unstructured":"Fuss A, Mazigo HD, Tappe D, Kasang C, Mueller A. Comparison of sensitivity and specificity of three diagnostic tests to detect Schistosoma mansoni infections in school children in Mwanza region, Tanzania. PLoS ONE. 2018;13:e0202499.","journal-title":"PLoS ONE"},{"key":"7497_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003139","volume":"8","author":"PH Lamberton","year":"2014","unstructured":"Lamberton PH, Kabatereine NB, Oguttu DW, Fenwick A, Webster JP. Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre-and post-repeated-praziquantel treatment. PLoS Negl Trop Dis. 2014;8:e3139.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2021.105871","volume":"218","author":"HD Mazigo","year":"2021","unstructured":"Mazigo HD, Fuss A, Mueller A. High Egg Reduction Rate but poor clearance of Circulating Cathodic Antigen three weeks after Praziquantel treatment among school children on Ijinga Island, north-western Tanzania. Acta Trop. 2021;218:105871.","journal-title":"Acta Trop"},{"key":"7497_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006054","volume":"11","author":"AO Kildemoes","year":"2017","unstructured":"Kildemoes AO, Vennervald BJ, Tukahebwa EM, Kabatereine NB, Magnussen P, de Dood CJ, et al. Rapid clearance of Schistosoma mansoni circulating cathodic antigen after treatment shown by urine strip tests in a Ugandan fishing community-Relevance for monitoring treatment efficacy and re-infection. PLoS Negl Trop Dis. 2017;11:e0006054.","journal-title":"PLoS Negl Trop Dis"},{"key":"7497_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2019.105049","volume":"197","author":"AG Viana","year":"2017","unstructured":"Viana AG, Gazzinelli-Guimar\u00e3es PH, de\u00a0Castro VN, Dos\u00a0Santos YLdO, Ruas ACL, Bezerra FSdM, et\u00a0al. Discrepancy between batches and impact on the sensitivity of point-of-care circulating cathodic antigen tests for Schistosoma mansoni infection. Acta Tropica. 2019;197:105049.","journal-title":"Acta Tropica"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-026-07497-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07497-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07497-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:19:59Z","timestamp":1783430399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13071-026-07497-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7497"],"URL":"https:\/\/doi.org\/10.1186\/s13071-026-07497-9","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data collection and use were reviewed and approved by the Oxford Tropical Research Ethics Committee (OxTREC 509-21), the Vector Control Division Research Ethics Committee of the Uganda Ministry of Health (VCDREC146), and the Uganda National Council for Science and Technology (UNCST HS1664ES). Written informed consent was obtained from all adults, who also consented on behalf of those under 18 years of age. All children provided informed verbal assent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}